1.Application of Mycoplasma pneumoniae antibody and load index in the diagnosis of Mycoplasma pneumoniae pneumonia in children.
Hui XIE ; Ji-Ming LI ; Hui-Fen ZHANG ; Ye WANG ; Li-Lin ZHONG ; Qing-Rong LIAN ; Hong-Ba DONG
Chinese Journal of Contemporary Pediatrics 2016;18(10):984-987
OBJECTIVETo study the role of Mycoplasma pneumoniae (MP) load and antibody measurements in the diagnosis of MP pneumonia.
METHODSA total of 115 children with MP pneumonia and 400 healthy children were enrolled. The MP load and total antibody level were measured at different stages, and the MP load index (MPLI) was calculated.
RESULTSThe cut-off value of MPLI for MP infection was 6.12. MPLI and total antibody titer increased during the course of the disease, while MP-DNA decreased rapidly. Within the same time of blood collection, the group with a higher MP load had a significantly higher total antibody titer than the group with a lower MP load (P<0.05). Within 2 weeks of the course of the disease, the negative antibody group had a significantly higher MPLI than the positive antibody group (P<0.05).
CONCLUSIONSMPLI provides a standardized quantitative value of MP-DNA and plays an important role in the early diagnosis of MP infection.
Antibodies, Bacterial ; blood ; Child ; Child, Preschool ; DNA, Bacterial ; analysis ; Early Diagnosis ; Female ; Humans ; Infant ; Male ; Pneumonia, Mycoplasma ; diagnosis ; microbiology
2.External validation of the Cham score for ordering of blood cultures in emergency department patients with non-hospital acquired pneumonia.
Mark PATTERSON ; Annemaree KELLY ; Sharon KLIM
Annals of the Academy of Medicine, Singapore 2014;43(3):166-169
INTRODUCTIONThe aim of this study was to externally validate the Cham score for the prediction of bacteraemia in emergency department (ED) patients with non-hospital acquired pneumonia.
MATERIALS AND METHODSThis is a secondary analysis of a dataset collected to identify independent predictors of bacteraemia in adult ED patients with non-hospital acquired pneumonia. The primary outcome of interest was the predictive performance (sensitivity, specificity, negative predictive value) of the score with respect to bacteraemia. Secondary outcomes included the performance of the score in patients not known to be intravenous (IV) drug users, the predictive performance of pneumonia severity index (PSI) class IV/V and PSI class IV/V or IV drug use as predictors and the clinical impact of score application on test ordering. Data analysis was by clinical performance and receiver operator characteristic curve analysis.
RESULTSA total of 200 patients were studied; 14 true positive blood cultures (7%, 95% CI, 4% to 11%). The Cham score had a sensitivity of 92.9% (95% CI, 64.2% to 99.6%), specificity of 26.3% (95% CI, 20.3% to 33.4%) and negative predictive value (NPV) of 98% (87.0% to 99.9%). Area under the receiver operating characteristic (ROC) curve was 0.71 (95% CI, 0.56 to 0.86). Using PSI class IV/V or known IV drug use as predictors had sensitivity of 92.9% (95% CI, 64.2% to 99.6%), specificity of 51.1% (95% CI, 43.7% to 58.4%) and NPV of 99% (95% CI, 93.5% to 99.9%).
CONCLUSIONIn retrospective external validation, the Cham score performed better than in derivation with acceptable sensitivity and NPV. Simplified criteria (PSI class IV/V or known IV drug use), as yet not validated, had similar sensitivity and NPV but would avoid blood cultures in a higher proportion of patients.
Aged ; Aged, 80 and over ; Bacteremia ; blood ; diagnosis ; Bacteriological Techniques ; utilization ; Emergency Service, Hospital ; Female ; Hematologic Tests ; utilization ; Humans ; Male ; Middle Aged ; Pneumonia, Bacterial ; blood ; microbiology ; Retrospective Studies
3.Clinical factors associated with composition of lung microbiota and important taxa predicting clinical prognosis in patients with severe community-acquired pneumonia.
Sisi DU ; Xiaojing WU ; Binbin LI ; Yimin WANG ; Lianhan SHANG ; Xu HUANG ; Yudi XIA ; Donghao YU ; Naicong LU ; Zhibo LIU ; Chunlei WANG ; Xinmeng LIU ; Zhujia XIONG ; Xiaohui ZOU ; Binghuai LU ; Yingmei LIU ; Qingyuan ZHAN ; Bin CAO
Frontiers of Medicine 2022;16(3):389-402
Few studies have described the key features and prognostic roles of lung microbiota in patients with severe community-acquired pneumonia (SCAP). We prospectively enrolled consecutive SCAP patients admitted to ICU. Bronchoscopy was performed at bedside within 48 h of ICU admission, and 16S rRNA gene sequencing was applied to the collected bronchoalveolar lavage fluid. The primary outcome was clinical improvements defined as a decrease of 2 categories and above on a 7-category ordinal scale within 14 days following bronchoscopy. Sixty-seven patients were included. Multivariable permutational multivariate analysis of variance found that positive bacteria lab test results had the strongest independent association with lung microbiota (R2 = 0.033; P = 0.018), followed by acute kidney injury (AKI; R2 = 0.032; P = 0.011) and plasma MIP-1β level (R2 = 0.027; P = 0.044). Random forest identified that the families Prevotellaceae, Moraxellaceae, and Staphylococcaceae were the biomarkers related to the positive bacteria lab test results. Multivariable Cox regression showed that the increase in α-diversity and the abundance of the families Prevotellaceae and Actinomycetaceae were associated with clinical improvements. The positive bacteria lab test results, AKI, and plasma MIP-1β level were associated with patients' lung microbiota composition on ICU admission. The families Prevotellaceae and Actinomycetaceae on admission predicted clinical improvements.
Acute Kidney Injury/complications*
;
Bacteria/classification*
;
Chemokine CCL4/blood*
;
Community-Acquired Infections/microbiology*
;
Humans
;
Lung
;
Microbiota/genetics*
;
Pneumonia, Bacterial/diagnosis*
;
Prognosis
;
RNA, Ribosomal, 16S/genetics*
4.Clinical Investigation of Cavitary Tuberculosis and Tuberculous Pneumonia.
Ki Man LEE ; Kang Hyeon CHOE ; Sung Jin KIM
The Korean Journal of Internal Medicine 2006;21(4):230-235
BACKGROUND: The radiographic characteristics of tuberculous pneumonia in adults are similar to primary tuberculosis that occurs in childhood, and upper lobe cavitary tuberculosis is the hallmark of postprimary tuberculosis. The purpose of this study was to investigate the factors associated with tuberculous pneumonia by making comparison with cavitary tuberculosis. METHODS: The medical records and radiographic findings of patients with cavitary tuberculosis and tuberculous pneumonia, and who were diagnosed between March 2003 and February 2006, were analyzed retrospectively. RESULTS: Forty patients had cavitary tuberculosis and sixteen patients had tuberculous pneumonia. Fever was more frequent for tuberculous pneumonia, whereas hemoptysis was more frequent for cavitary tuberculosis. The duration of symptoms before visiting the hospital was shorter, but the diagnosis after admission was more delayed for tuberculous pneumonia patients than for cavitary tuberculosis patients. The prevalence of underlying comorbidities such cancer, diabetes, alcoholism and long-term steroid use was not different between the two groups. The patients with tuberculous pneumonia were older and they had lower levels of serum albumin and hemoglobin than those with cavitary tuberculosis. The patients with tuberculous pneumonia showed a tendency to have more frequent endobronchial lesion. Tuberculous pneumonia occurred in any lobe, whereas the majority of cavitary tuberculosis patients had upper lung lesion, but the prevalence of lymphadenopathy, pleural effusion and previous tuberculosis scar was not different between the two groups. CONCLUSIONS: Older age, a lower level of serum albumin and hemoglobin and a random distribution of lesion were associated with tuberculosis pneumonia as compared with cavitary tuberculosis. These findings suggest that the pathogenesis of tuberculous pneumonia might be different from that of cavitary tuberculosis.
Tuberculosis, Pulmonary/blood/*diagnosis/microbiology
;
Tomography, X-Ray Computed
;
Sputum/microbiology
;
Severity of Illness Index
;
Serum Albumin/metabolism
;
Retrospective Studies
;
Radiography, Thoracic
;
Pneumonia, Bacterial/blood/*diagnosis/microbiology
;
Mycobacterium tuberculosis/isolation & purification
;
Middle Aged
;
Male
;
Lung/microbiology/pathology/radiography
;
Humans
;
Hemoglobins/metabolism
;
Female
;
Diagnosis, Differential
;
Bronchoscopy
;
Biopsy
;
Adult
5.Inflammatory pseudotumor of the lung in a child with mycoplasma pneumonia.
Sung Hye PARK ; Ghee Young CHOE ; Chul Woo KIM ; Je G CHI ; Sook Hwan SUNG
Journal of Korean Medical Science 1990;5(4):213-223
A case of inflammatory pseudotumor of the lung occurring in a six-year-old boy is reported with clinicopathologic findings, including its ultrastructure. The patient had had frequent upper respiratory tract infections, and one and half year before the discovery of the lung mass, he suffered from pneumonia of the right lung, which was serologically proven to be a mycoplasma pneumoniae infection. Exploratory thoracotomy revealed a large mediastinal mass that was removed together with the right middle and lower lobes of the lung. The mass arose from the lung with an endobronchial element. Microscopically, the mass was composed of a variety of inflammatory and mesenchymal cells, including plasma cells, histiocytes, lymphocytes, and fibroblast-like spindle cells. Ultrastructurally, the spindle-shaped mesenchymal cells were either fibroblasts or myofibroblasts. At the time of diagnosis of the inflammatory pseudotumor of the lung, the serum titer of antimycoplasma antibody rose again, and the lung parenchyma adjacent to the mass showed interstitial pneumonia with features of bronchiolitis obliterans. The present case suggests that the inflammatory pseudotumor of the lung could be a postinflammatory lesion associated with mycoplasma pneumoniae infection.
Antibodies, Bacterial/blood
;
Bronchiolitis Obliterans/complications
;
Child
;
Diagnosis, Differential
;
Fibroma/etiology/*pathology/surgery
;
Humans
;
Lung Neoplasms/etiology/*pathology/surgery
;
Male
;
Mycoplasma pneumoniae/immunology/*pathogenicity
;
Pneumonia, Mycoplasma/complications/microbiology/*pathology
;
Tomography, X-Ray Computed
6.Mycoplasma pneumoniae-associated mucositis: a case report.
Jing YIN ; Xiaojie LI ; Li LIU ; Jian HU ; Chongwei LI
Chinese Journal of Pediatrics 2014;52(5):399-400
Anti-Bacterial Agents
;
administration & dosage
;
therapeutic use
;
Anti-Inflammatory Agents
;
therapeutic use
;
Azithromycin
;
administration & dosage
;
therapeutic use
;
Biomarkers
;
blood
;
Child
;
Eyelids
;
pathology
;
Humans
;
Immunoglobulin M
;
blood
;
Lip
;
pathology
;
Male
;
Methylprednisolone
;
administration & dosage
;
therapeutic use
;
Mucositis
;
diagnosis
;
drug therapy
;
microbiology
;
Mycoplasma pneumoniae
;
drug effects
;
isolation & purification
;
Pneumonia, Mycoplasma
;
complications
;
diagnosis
;
drug therapy